Brought to you by:
The CLTI conundrum: My spirited journey through the CLTI saga
Welcome to the CLTI Chronicles, a saga of mystery, medicine and misadventures in limb salvage unfolding weekly in my office, where the drama of threatened limbs rivals any Latin telenovela. My clinic has become a crossroads for the second opinion…
VQI analysis of CLTI practice following BEST-CLI finds no pick up in bypass rate
A Vascular Quality Initiative (VQI) analysis of evolving practice in the wake of the BEST-CLI trial demonstrated no increase in the rate of surgical bypass in the year afterwards. More analysis needs to be done comparing the data pre- and…
Pilot study looks at undiagnosed vascular disease in homeless
A pilot study in Canadian capital Ottawa aimed at uncovering the extent of undiagnosed vascular disease among the city’s homeless population detected a subset who may be in need of treatment for venous disease. The work was carried out by…
‘Select CLTI patients may be safely treated in the office-based lab’
Results from a single-center analysis show the outpatient setting met SVS objective performance goals. A retrospective study of endovascular interventions performed for chronic limb-threatening ischemia (CLTI) in an office-based lab (OBL) associated with a large New York City medical center…
Shockwave Medical expands US peripheral IVL portfolio with enhanced catheter
Shockwave Medical, part of Johnson & Johnson MedTech, has announced the full U.S. launch of its Shockwave E8 peripheral intravascular lithotripsy (IVL) catheter, following clearance by the Food and Drug Administration (FDA). A company press release details that the Shockwave…
The top 10 most popular Vascular Specialist stories of August 2024
In August, the most read stories from Vascular Specialist included a research letter addressing ‘alarmingly high’ mortality rates in chronic limb-threatening ischemia (CLTI) patients; a new book published due to the SVS History Work Group’s recent project; new funding for the development…
SCOREPAD seeks to address ‘alarmingly high’ mortality in CLTI patients with underlying coronary disease
A new research letter underscores the need to improve long-term survival following lower extremity revascularization for chronic limb-threatening ischemia (CLTI), setting out a randomized controlled trial to examine the impact of coronary artery ischemia testing in these patients. The letter,…
CIRSE begins CALCIO trial enrolment for treatment of CLTI with Shockwave IVL system
The Cardiovascular and Interventional Society of Europe (CIRSE) have announced that patient enrolment for the CALCIO trial has begun. CALCIO started patient enrolment on 15 July, 2024, with the goal of recruiting 400 chronic limb-threatening ischaemia (CLTI) patients over the…
Endovascular CFA treatment associated with increased rate of long-term CFA-specific reintervention, study finds
A recent study suggests that endovascular treatment of the common femoral artery (CFA) is associated with an increased rate of long-term CFA-specific reintervention, regardless of indication. Nicholas Wells, a medical student at Yale School of Medicine in New Haven, USA,…
Sex-based analysis finds BEST-CLI data generalizable to female patients
A new secondary analysis of sex disparities in the best endovascular versus best surgical therapy in patients with critical limb ischemia (BEST-CLI) trial data has found that improved major adverse limb event (MALE)-free survival via open surgical bypass with single…